Chenxi Hu Selected Research

Chenxi Hu Research Topics

Disease

18	Neoplasms (Cancer) 01/2024 - 01/2016
9	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2024 - 01/2019
2	Carcinogenesis 01/2024 - 01/2016
2	Dry Eye Syndromes (Dry Eye Syndrome) 01/2021 - 01/2021
2	Inflammation (Inflammations) 04/2020 - 04/2019
2	Fibrosis (Cirrhosis) 01/2019 - 01/2018
2	Pancreatic Neoplasms (Pancreatic Cancer) 11/2017 - 09/2017
1	Prostatic Neoplasms (Prostate Cancer) 01/2024
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2024
1	Malignant Pleural Effusion 01/2024
1	Neoplasm Metastasis (Metastasis) 01/2024
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 04/2023
1	Edema (Dropsy) 01/2022
1	Cardiomyopathies (Cardiomyopathy) 01/2022
1	Arthritis (Polyarthritis) 01/2022
1	Infections 04/2020
1	Carcinoma (Carcinomatosis) 04/2020
1	Lung Neoplasms (Lung Cancer) 02/2019
1	Hypoxia (Hypoxemia) 01/2019
1	Cardiac Arrhythmias (Arrythmia) 01/2019
1	Ascites 11/2017
1	Adenocarcinoma 09/2017
1	Warts (Wart) 09/2017
1	Cicatrix (Scar) 08/2017
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 06/2014
1	Leukemia 06/2014
1	Vesicular Stomatitis 02/2014

Drug/Important Bio-Agent (IBA)

5	Proteins (Proteins, Gene)FDA Link 01/2024 - 09/2017
4	anlotinibIBA 10/2022 - 02/2019
4	GadoliniumIBA 01/2022 - 01/2018
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2024 - 01/2016
2	AntigensIBA 01/2024 - 09/2019
2	Circular RNAIBA 01/2024 - 01/2024
2	RNA (Ribonucleic Acid)IBA 01/2024 - 01/2022
2	LuciferasesIBA 01/2024 - 04/2020
2	N-methyladenosineIBA 04/2023 - 01/2022
2	CytokinesIBA 01/2021 - 04/2020
2	apatinibIBA 09/2019 - 11/2017
2	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 01/2019 - 01/2016
1	LigandsIBA 02/2024
1	Long Noncoding RNAIBA 01/2024
1	DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA 01/2024
1	Peptides (Polypeptides)IBA 01/2024
1	Conditioned Culture MediaIBA 01/2024
1	endostar proteinIBA 01/2024
1	envafolimabIBA 01/2024
1	Particulate MatterIBA 04/2023
1	6-methyladenineIBA 01/2022
1	Messenger RNA (mRNA)IBA 01/2022
1	MethyltransferasesIBA 01/2022
1	Fluorescent Dyes (Fluorescent Probes)IBA 01/2022
1	EnzymesIBA 01/2021
1	Neutralizing AntibodiesIBA 01/2021
1	pigment epithelium-derived factorIBA 01/2021
1	ImmunosorbentsIBA 01/2021
1	MicroRNAs (MicroRNA)IBA 11/2020
1	Interleukin-2 (IL2)IBA 04/2020
1	Inflammation MediatorsIBA 04/2020
1	CaspasesIBA 04/2020
1	SaponinsIBA 04/2020
1	Reactive Oxygen Species (Oxygen Radicals)IBA 04/2020
1	matrigelIBA 07/2019
1	Matrix Metalloproteinases (MMPs)IBA 04/2019
1	Chloroquine (Aralen)FDA LinkGeneric 02/2019
1	Cyclin D1IBA 01/2019
1	Biomarkers (Surrogate Marker)IBA 01/2019
1	UbiquitinIBA 01/2019
1	Peptide Hydrolases (Proteases)FDA Link 01/2019
1	Gemcitabine FDA Link 11/2017
1	Protons (Proton)IBA 08/2017
1	Angiogenesis InhibitorsIBA 04/2017
1	Fibronectins (Fibronectin)IBA 01/2016
1	Liposomes (Liposome)IBA 06/2014
1	Ganciclovir (Cytovene)FDA LinkGeneric 02/2014
1	Thymidine KinaseIBA 02/2014
1	Membrane Proteins (Integral Membrane Proteins)IBA 02/2014
1	Glycoproteins (Glycoprotein)IBA 02/2014

Therapy/Procedure

8	Therapeutics 02/2024 - 01/2016
2	Radiotherapy 07/2019 - 01/2016
1	Aftercare (After-Treatment) 01/2021
1	Chinese Traditional Medicine (Traditional Chinese Medicine) 04/2020
1	Traditional Medicine (Folk Remedies) 04/2020
1	Immunotherapy 04/2017
1	Drug Therapy (Chemotherapy) 01/2016
1	Quantum Dots (Quantum Dot) 06/2014